Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-17

FDA Approved: CISPLATIN — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved Sagent Pharmaceuticals' original application for cisplatin, a generic injectable chemotherapy agent (ANDA approval).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)

Snippet

ORIG AP for CISPLATIN (CISPLATIN)